The coupling between synaptic activity and glucose utilization (neurometabolic coupling) is a central physiologic principle of brain function that has provided the basis for 2-deoxyglucose-based functional imaging with positron emission tomography. Approximately 10 y ago we provided experimental evidence that indicated a central role of glutamate signaling on astrocytes in neurometabolic coupling. The basic mechanism in neurometabolic coupling is the glutamatestimulated aerobic glycolysis in astrocytes, such that the sodiumcoupled reuptake of glutamate by astrocytes and the ensuing activation of the Na + -K + ATPase triggers glucose uptake and its glycolytic processing, which results in the release of lactate from astrocytes. Lactate can then contribute to the activity-dependent fueling of the neuronal energy demands associated with synaptic transmission. Analyses of this coupling have been extended in vivo and have defined the methods of coupling for inhibitory neurotransmission as well as its spatial extent in relation to the propagation of metabolic signals within the astrocytic syncytium. On the basis of a large body of experimental evidence, we proposed an operational model, "the astrocyte-neuron lactate shuttle." A series of results obtained by independent laboratories have provided further support for this model. This body of evidence provides a molecular and cellular basis for interpreting data that are obtained with functional brain imaging studies.
INTRODUCTION
As initially postulated by Roy and Sherrington (1), a tight coupling exists between neuronal activity and local vascular responses: "the brain possesses an intrinsic mechanism by which its vascular supply can be varied locally in correspondence with local variations of functional activity" (1) . Since the work of Sokoloff et al (2) in the 1970s, we know that this coupling is also operational for glucose utilization, as shown by the 2-deoxyglucose (2-DG) technique and, in particular, its application to positron emission tomography (PET). The question of the molecular and cellular mechanisms that underlie this coupling between the electrochemical events that occur at the synapse and the local vascular and metabolic responses observed in register with synaptic activity has remained elusive for more than a century after Sherrington's proposal. Several candidates have been proposed; however, most of them appear to be too unspecific and, in some instances, too slow to provide an explanation for neurovascular and neurometabolic coupling.
In recent years, it has appeared that glutamate and the signaling cascades triggered by its interaction with receptors and reuptake sites could play a key role in coupling synaptic activity to metabolic and vascular responses. This appears to be a rather economical and straightforward way to operate this coupling because glutamate is the main neurotransmitter in the cortex and .85% of all synapses in the cortex are glutamatergic (3) . Indeed, observations have been made that indicate that glutamate may be the main signal involved in coupling synaptic activity to metabolic responses and vascular supply. In addition, a glial cell type, the astrocyte, appears to be central in detecting glutamatergic activity and coupling it with metabolic and vascular responses (4, 5) .
A recapitulation of glutamate signaling at the synapse and its extrasynaptic targets involving astrocytes and intraparenchymal capillaries provides a first set of data to unravel the molecular mechanisms that underlie the coupling between synaptic activity and metabolic and vascular responses. Elucidation of these mechanisms is not only important to better understand physiologic principles of brain function but also to provide a clear understanding of the signals that are detected with functional brain imaging techniques, such as PET and functional magnetic resonance imaging, which detect metabolic or vascular signals that are coupled to synaptic activity.
ROLE OF GLUTAMATE IN CELL-CELL SIGNALING IN THE BRAIN
The primary effectors of glutamate-mediated signaling on its target cells are sodium and calcium ions, which are responsible for the changes in excitability and the triggering of intracellular cascades that mediate glutamatergic transmission. Indeed, at postsynaptic sites, glutamate interacting at AMPA (a-amino-3-hydroxy-5-methylisoxazole-4-propionic acid) and NMDA (N-methyl-D-aspartate) receptors modifies the permeability to sodium (AMPA receptors) and sodium and calcium (NMDA receptors), which results in the generation of excitatory postsynaptic potentials that mediate the fundamental effects of glutamate on excitability and synaptic plasticity. Metabotropic glutamate receptors also operate changes in calcium signaling through GTP-mediated processes. In turn, changes in intracellular calcium triggered by NMDA and metabotropic receptors activate intracellular signaling cascades that range from calcium-dependent phosphorylations to a wide range of intracellular calcium-dependent processes. At the presynaptic level, NMDA and metabotropic receptors, again through calcium signaling, modulate the properties of the presynaptic terminals.
Evidence is accumulating that glutamate does not act exclusively on neurons but also on nonneuronal cells, and in particular astrocytes. A well-established signaling mechanism between neurones and astrocytes involving glutamate is glutamate uptake by astrocytes, a process operated by glutamate transporters (glutamate transporter-1 and L-glutamate/L-aspartate transporter), which uses the electrochemical gradient of sodium as the driving force. The stoichiometry for glutamate uptake by astrocytes is 3 sodium ions per glutamate molecule. This sodium entry has been shown to represent not only an "electrophysiological" phenomenon generating a transient sodium current but also a "biochemical" signaling because the sodium entry associated with glutamate uptake disrupts intracellular sodium homeostasis. We have shown that this sodium-mediated signaling provides a faithful signaling mechanism to couple synaptic activity to glucose utilization by astrocytes (4).
ROLE OF GLUTAMATE IN COUPLING SYNAPTIC ACTIVITY TO GLUCOSE UTILIZATION
Indeed, a vast array of experimental and clinical evidence has indicated the existence of a tight coupling between methodspecific brain activation and localized increases in glucose utilization (2) . As noted earlier, the 2-DG technique developed by Sokoloff for laboratory animals (2) and its adaptation to PET for humans has provided a direct demonstration of the coupling between neuronal activation and glucose utilization. Despite this compelling evidence, the cellular and molecular mechanisms that underlie such a coupling are still under scrutiny. A long-held assumption was that neuronal signals produced by synaptic activity act directly on brain capillaries to increase locally the delivery of energy substrates. However, this view does not take into account an important cellular component of the brain: the astrocytes. Indeed, particular astrocytic profiles, the end-feet, surround intraparenchymal capillaries, whereas other astrocytic processes ensheath synaptic contacts and possess receptors and reuptake sites for neurotransmitters (6) . These features imply that astrocytes are ideally positioned to sense increases in synaptic activity and to couple them with energy metabolism. Thus, a cellular "triad" consisting of the capillaries, the astrocytes, and the neuropil has become the center of attention in considering the local regulation of brain energy metabolism in register with neuronal activity (Figure 1) .
Glutamate is the predominant excitatory neurotransmitter in the brain. In the cerebral cortex, activation of afferent pathways by specific methods (eg, somatosensory, visual, auditory) or of cortico-cortical association circuits results in a spatially and temporally defined local release of glutamate from the activated synaptic terminals (7) . The released glutamate exerts profound effects on the excitability of target neurons, which are mediated by specific subtypes of glutamate receptors. The action of glutamate on postsynaptic neurons is rapidly terminated by an avid reuptake system present on astrocyte processes, which ensheath synaptic contacts (8, 9) . This removal of glutamate from the synaptic cleft is operated through specific glutamate transporters, 2 of which are predominantly, if not exclusively, expressed on astrocytes. These are glutamate transporter-1 and L-glutamate/Laspartate transporter. Glutamate uptake into astrocytes is driven by the electrochemical gradient of sodium, which implies that it is a sodium-dependent mechanism involving the cotransport of glutamate with 3 sodium ions.
ASTROCYTES AS THE TARGET FOR THE ROLE OF GLUTAMATE IN NEUROMETABOLIC COUPLING
From the foregoing, we postulated that astrocytes may play a prominent role in coupling neuronal activity to local increases in glucose utilization during activation as observed in animals and humans. To explore this hypothesis we have studied glucose utilization by mouse cerebral cortex astrocytes in culture with the use of the 3 H-2-DG as a marker of glucose utilization. We have shown that glutamate stimulates 2-DG uptake and phosphorylation in astrocytes in a concentration-dependent manner with an EC 50 (effective concentration of 50% inhibition) of '80 lmol/L (4). This effect is not receptor-mediated because it cannot be prevented nor mimicked by glutamate receptor antagonists and agonists, respectively (4). Rather, the involvement of a Na + -dependent glutamate transporter is strongly supported by a set of pharmacologic evidence. Indeed the glutamate-mediated increase in glucose utilization is mimicked by D-aspartate but not D-glutamate, a pharmacologic signature for an effect mediated by glutamate transporters; as expected from a phenomenon mediated by a Na + -dependent process such as the glutamate transport, removal of extracellular Na + inhibits the metabolic effect of glutamate (4, 10) . Finally, inhibition of glutamate uptake by known transporter inhibitors such as threo-hydroxyaspartate results in the inhibition of the glutamate-stimulated glucose utilization by astrocytes (6) . These results clearly indicate a tight coupling between Na + -dependent glutamate uptake and glucose utilization by astrocytes (Figure 1 ), a finding later confirmed by Takahashi et al (10) . The critical role of glutamate transporters FIGURE 1. Schematic representation of the cytologic relation among astrocytes, neurons, and capillaries. Astrocytes form the first cellular barrier encountered by glucose entering the brain parenchyma and are likely a prevalent uptake site because they express glucose transporters of the GLUT-1 type (B). They are also ideally located to sense synaptic activity (A), because one of their main functions is to clear glutamate and potassium accumulating in the extracellular space after neuronal activation.
in coupling synaptic activity to glucose utilization has also been confirmed in vivo (11, 12) .
The intracellular molecular mechanism(s) of this coupling are now beginning to be elucidated; a critical involvement of the Na + -K + ATPase is likely because ouabain completely inhibits the glutamate-evoked 2-DG uptake by astrocytes (4, 13) . Indeed, recent evidence obtained in our laboratory with the use of 86 Rubidium uptake to directly monitor the activity of the pump shows that glutamate activates the Na + -K + ATPase (13) . This effect of glutamate is likely due to the mobilization of a subunit of the pump which is highly sensitive to ouabain, probably the a 2 subunit (14) .
There is ample evidence from studies in a variety of cellular systems, including the brain, kidney, vascular smooth muscle, and erythrocytes, that increases in the activity of the Na + -K + ATPase stimulate glucose uptake and glycolysis (15, 16) . Consistent with this view, glutamate stimulates the glycolytic processing of glucose in astrocytes, as indicated by the increase in lactate release (4) . These data indicate that glutamate stimulates aerobic glycolysis (ie, the transformation of glucose into lactate in the presence of sufficient oxygen) in astrocytes by a mechanism involving an activation of the Na + -K + ATPase.
GLUTAMATE-STIMULATED LACTATE PRODUCTION BY ASTROCYTES PROVIDES AN ENERGY SOURCE FOR NEURONS
This view raises the question of the usefulness of lactate as an energy substrate for neurons. A vast array of experimental data has accumulated over the years, indicating that in vitro lactate can adequately maintain synaptic activity in the absence of glucose (17, 18) . In vivo, lactate is not an adequate substrate because it crosses only marginally the blood-brain barrier (19) ; however, if formed within the brain parenchyma through the mechanism described above (Figure 1) , or if applied to in vitro preparations, lactate may in fact be consumed preferentially to glucose, particularly during periods of intense activity (18) .
Because lactate can be used as an energy fuel by neurons, we considered the possibility that a selective distribution of lactate dehydrogenase (LDH) isoenzymes could exist among lactateproducing and lactate-consuming cells. Indeed, LDH is the enzyme that catalyzes the interconversion of lactate and pyruvate. We have raised polyclonal antibodies against the LDH 1 (hearttype) and the LDH 5 (muscle-type) subunits and used them for immunohistochemistry of human hippocampus and visual cortex. The results show that the immunoreactivity against LDH 5 (the form enriched in lactate-producing tissues) is restricted to a population of astrocytes, whereas neurons are stained only by an antibody directed against LDH 1 (the form enriched in lactateconsuming tissues) (20) . These data thus support the idea that some astrocytes would preferentially process glucose glycolytically into lactate, which, once released, could be transformed by neurons into pyruvate and enter the tricarboxylic acid (TCA) cycle to serve as an energy fuel. It should be stressed that one molecule of lactate entering the TCA cycle through the LDHcatalyzed reaction can yield, in normoxic conditions, 17 ATPs. Simpson et al (21) have argued that a significant uptake of glucose occurs in neurons, which could in turn release lactate to be taken up by astrocytes. Although the model proposed by Pellerin and Magistretti (4) never did preclude the existence of glucose uptake by neurons as already included in the first description of the model in particular for basal conditions, the conclusions of Simpson et al (21) should be considered with caution. Indeed, the conclusions are mainly derived from a quantitative model of glucose uptake in neurons compared with astrocytes based on semiquantitative experimental data of glucose transporter densities originating from several different preparations with significant density ranges and assumptions. Thus, it seems difficult to derive quantitative conclusions for modeling from qualitative or at best semiquantitative experimental data. Further questioning the proposed predominant role of glucose uptake into neurons, recent in vivo data indicate that heterozygous knockout mice for the neuronal glucose transporter (Glut3) do not present any notable behavioral phenotype or cognitive impairment (22) . This observation stands in stark contrast with the major abnormalities in nervous system function in knockout mice heterozygous for Glut1, the astrocytespecific glucose transporter (23) . These data point to a major role of glucose uptake into astrocytes for normal neural function. In addition, Rouach et al (24) recently provided direct evidence for a role of lactate released by astrocytes in sustaining synaptic activity.
In summary, because glutamate release occurs after the method-specific activation of a brain region, these data and the proposed model are consistent with the view that, during activation, glutamate uptake into astrocytes leads to increased glucose utilization and lactate production, which can be subsequently used by neurons to meet their energy needs. Further support for this notion of an "astrocyte-neuron lactate shuttle" in the brain (Figure 2) has been provided by the identification of 2 lactate transporters, MCT-1 (monocarboxylate transporter-1) and MCT-2, selectively expressed in astrocytes or neurons. Thus, MCT-1 is enriched in astrocytes in culture, whereas MCT-2 is predominantly expressed in neurons (26) .
RELEVANCE TO FUNCTIONAL BRAIN IMAGING
Results obtained in a variety of in vivo paradigms both in laboratory animals and in humans support the existence of such a transient lactate production during activation. Thus, marked increases in the concentration of extracellular lactate have been monitored by microdialysis studies in rat striatum and hippocampus during physiologic sensory stimulation (27) . This activity-linked increase in lactate is completely inhibited by the glutamate uptake inhibitor threo-hydroxyaspartate, thus providing further support for the existence of glutamate-stimulated glycolysis during activation (28) . Magnetic resonance spectroscopy (MRS) in humans has also shown that, during physiologic activation of the visual system, a transient lactate peak is observed in primary visual cortex (29) . These microdialysis and MRS data in vivo would support the notion of a transient glycolytic processing of glucose during activation.
The model proposed for the coupling between neuronal activity and glucose utilization, on the basis of studies at the cellular level (Figure 2 ), would be consistent with an initial glycolytic processing of glucose occurring in astrocytes during activation, resulting in a transient lactate overproduction, followed by a recoupling phase during which time lactate would be oxidized by neurons. The spatiotemporal "window" during which a lactate peak could be detected by MRS would depend on the rapidity and degree of recoupling existing between astrocytic glycolysis and neuronal oxidative phosphorylation.
Finally, the model proposed in Figure 2 is consistent with the notion that the signals detected during physiologic activation in humans with 18 F 2-DG PET and autoradiography in laboratory animals may reflect predominantly uptake of the tracer into astrocytes (4, 6 ). This conclusion does not question the validity of the 2-DG-based techniques, rather it provides a cellular and molecular basis for these functional brain imaging techniques.
This model seems to apply only to excitatory neurotransmission mediated by glutamate. Indeed, we observed that c-aminobutyric acid (GABA) uptake into astrocytes is not associated with significant metabolic cost, which suggests that c-aminobutyric acid may not couple inhibitory neuronal activity with glucose utilization and thus not contribute directly to brain imaging signals associated with transient glycolytic processing of glucose (30) .
OTHER SIGNALING MECHANISMS OF GLUTAMATE ON ASTROCYTES
Glutamate can also activate AMPA and metabotropic glutamate receptors on astrocytes. The function of AMPA receptormediated signaling in astrocytes still needs to be clarified, but activation of metabotropic receptors results, such as in neurones, in an increase in calcium which can then trigger a variety of calcium-dependent intracellular processes. This action of glutamate on astrocytes, in addition to its sodium-mediated metabolic effect, was also shown to provide signaling mechanisms that affect blood flow. Indeed, several groups have shown that glutamate-mediated synaptic activity leads to the formation of nitric oxide and to prostanoids that were all previously identified as potent agents able to modify blood flow locally (5).
Thus, sodium and calcium signaling operated by specific glutamate-sensing molecules such as receptors and transporters appears to be at the center of communication at the neuron-glialvascular unit and to provide the coupling of synaptic activity with vascular and metabolic responses that produce the signals detected with functional brain imaging techniques. In addition, as shown by these imaging techniques, it is clear that disruption of this coupling is at the basis, or strongly involved, in a number of pathologic conditions such as neurodegenerative diseases and psychiatric disorders, including schizophrenia and depression.
GLUTAMATE AS A METABOLIC SUBSTRATE IN THE BRAIN
Glutamate, in addition to acting as a signaling molecule at the synaptic level as well as on astrocytes and indirectly on blood vessels, is also a metabolic intermediate of the TCA cycle and in the carbon flux in general. Indeed, glutamate taken up by astrocytes can follow different metabolic pathways. First, the amino group of glutamate can be transferred to oxaloacetate to yield a-keto glutarate (a-KG) and aspartate in a reaction catalyzed by aspartate amino transferase. The a-KG generated is an intermediate of the TCA cycle and is therefore oxidized further. Another pathway to convert glutamate to a-KG is mediated by glutamate dehydrogenase. Thus, glutamate by entering the TCA cycle either through aspartate amino transferase or glutamate dehydrogenase is an energy substrate for astrocytes.
A third metabolic pathway for glutamate in astrocytes is its amidation to glutamine in an ATP-requiring reaction in which an ammonium ion is fixed on glutamate. This reaction is catalyzed by glutamine synthase, an enzyme almost exclusively localized in astrocytes; this reaction provides an efficient means of disposing not only of glutamate but also of ammonium. Glutamine is then FIGURE 2. Model for coupling of synaptic activity with glucose utilization. At glutamatergic synapses, the action of glutamate is terminated by efficient glutamate uptake systems located in neuronal and astrocytic cell membranes (asterisk in figure identifies astrocytic transporter). The astrocytic uptake system involves the glutamate transporters GLT-1 (glutamate transporter-1) and GLAST (L-glutamate/L-aspartate transporter) [GLT-1 is also known as EAAT2 (excitatory amino acid transporter 2); GLAST is also known as EAAT1] (25) . Glutamate is cotransported with Na + , which results in an increase in the intracellular concentration of Na + and leads to the activation of the Na + -K + ATPase. Glutamate is converted to glutamine by glutamine synthase. Activation of the Na + -K + ATPase triggers aerobic glycolysis. Lactate produced by the glutamate-stimulated glycolysis is released from astrocytes. (A) Glucose uptake synaptic activation; (B) direct glucose uptake into neurons under basal conditions. Pyr, pyruvate; Lac, lactate; Gln, glutamine; G, G protein. Adapted from reference 9.
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MAGISTRETTI released by astrocytes and is taken up by neurons where it is hydrolyzed back to glutamate by glutaminase, thus contributing to the replenishment of the neurotransmitter pool of glutamate in neurons. This metabolic pathway, often referred to as the glutamate-glutamine shuttle, is a clear example of cooperation between astrocytes and neurons; it allows the removal of potentially toxic excess of glutamate from the extracellular space while returning to the neuron a synaptically inert (glutamine does not affect neurotransmission) precursor with which to regenerate the neuronal pool of glutamate. A complementary pathway to regenerate the neuronal glutamate pool also involves an astrocyteneuron cooperation. Indeed, a-KG can fix an amino group originating from leucine taken up by astrocytes from the circulation and result in the formation of glutamate that, after conversion to glutamine, is then released by astrocytes.
Yet another metabolic pathway related to the glutamate exchanges between the astrocytes and neurons should be pointed out in the context of this neuron-glia-vascular unit. Indeed, because a-KG is used for glutamate synthesis, metabolic intermediates downstream of it in the TCA cycle must be available to maintain a carbon flux through the cycle in astrocytes. This need is met by the activity of the enzyme pyruvate carboxylase that fixes carbon dioxide on pyruvate to generate oxaloacetate, a TCA cycle intermediate. The carboxylation of pyruvate to oxaloacetate is referred to as an anaplerotic (Greek for "fill up") reaction. Interestingly, like glutamine synthase, pyruvate carboxylase is selectively localized in astrocytes. Because these 2 enzymes are localized in astrocytes in conjunction with the existence of a glutamate-glutamine shuttle stresses the fact that astrocytes are essential for maintaining the neuronal glutamate pool used for neurotransmission.
Thus, the axon terminals of glutamatergic neurons, which are the main communication lines in the nervous system, and the astrocytic processes that surround them should be viewed as a "metabolic unit" in which the neuron furnishes the activation signal (glutamate) to the astrocytes and the astrocytes provide not only the precursors needed to maintain the neurotransmitter pool (glutamine) but also the energy substrate (lactate). The efficacy of the predominant excitatory synapse in the brain, the glutamatergic synapse, cannot be maintained without a close astrocyte-neuron interaction. The third partner in the neuronglia-vascular unit is the capillary, from which all the necessary precursors to maintain synaptic activity through the astrocyteneuron partnership originate. Finally, it is of historic interest that, consistent with the above findings, older studies that used labeled precursor-product paradigms suggested the existence of 2 pools of glutamate in brain, a small pool in astrocytes and a larger pool in neurons (31) .
CONCLUSIONS
Currently, a convergent set of data indicates that glutamate signaling on astrocytes provides a mechanism to tightly couple synaptic activity and glucose utilization. Additional data indicate that glutamate may also be involved in neurovascular coupling. Analyses of this coupling have been extended in vivo (11, 12) and have also defined the methods of coupling for inhibitory neurotransmission as well as its spatial extent in relation to the propagation of metabolic signals within the astrocytic syncytium (32) . On the basis of a large body of experimental evidence (for a recent review, see reference 33), we have proposed an operational model, "the astrocyte-neuron lactate shuttle" (34) . A series of results obtained by independent laboratories has provided further support for this model (35) (36) (37) (38) . This body of evidence provides a molecular and cellular basis for interpreting data obtained with functional brain imaging studies. (Other articles in this supplement to the Journal include references 39-67.) 
